Package 0591-5321-01

{"route": ["ORAL"], "spl_id": "237e4801-0ed5-4e50-a128-52f580f0b6d7", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0305915321012"], "unii": ["13AFD7670Q"], "rxcui": ["96304"], "spl_set_id": ["ae0fa704-818e-4423-8e3a-6cc3390cdd7d"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE, PLASTIC (0591-5321-01)", "package_ndc": "0591-5321-01", "marketing_start_date": "20100619"}], "brand_name": "Primidone", "product_id": "0591-5321_237e4801-0ed5-4e50-a128-52f580f0b6d7", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0591-5321", "generic_name": "Primidone", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Primidone", "active_ingredients": [{"name": "PRIMIDONE", "strength": "250 mg/1"}], "application_number": "ANDA083551", "marketing_category": "ANDA", "marketing_start_date": "20100619", "listing_expiration_date": "20261231"}